Can Wilson Disease Really Be Diagnosed in Your 50s or 60s?

Yes, Wilson disease can genuinely be diagnosed in your fifties or sixties. It is rarer than a diagnosis in childhood or early adulthood, but it is not a medical curiosity — documented case series and genetic studies confirm that a small but meaningful proportion of people with Wilson disease go undetected until middle age or later.¹² If you are in this situation, the confusion and shock are understandable. This page explains why late diagnosis happens, what it means for your health, and how treatment at this stage compares to what younger patients receive.

Why does Wilson disease sometimes stay hidden for decades?

Wilson disease is caused by mutations in the ATP7B gene, which controls how the body exports copper from the liver.³ Most people with two faulty copies of this gene begin accumulating copper quickly and develop symptoms in childhood or early adulthood — typically between ages 5 and 35.³ But not all mutations are equally damaging. Some variants produce a protein that still functions partially, slowing the rate of copper accumulation enough that symptoms emerge gradually over many years rather than suddenly.⁴

A 2020 study in Human Genetics found that the true genetic prevalence of Wilson disease in the population is substantially higher than the clinical prevalence — meaning many carriers of two disease-causing variants live for years without a diagnosis, and some may present only in midlife or later.⁴ A 2026 case report in the American Journal of Medical Genetics described a patient carrying the ATP7B p.Met665Ile variant — a hypomorphic (partially functional) mutation — who was first diagnosed in late adulthood, adding to growing evidence that reduced-penetrance variants can delay onset significantly.¹

Late presentations often look different from classic Wilson disease. Instead of the typical young-adult combination of liver disease plus neurological or psychiatric symptoms, an older patient might have:

• Unexplained elevated liver enzymes found incidentally during routine bloodwork
• A slowly progressive tremor or movement problem attributed for years to aging or essential tremor
• Mild psychiatric symptoms that were diagnosed as depression or anxiety
• Kayser-Fleischer rings discovered by an ophthalmologist examining the eyes for an unrelated reason

Because none of these alone screams “Wilson disease” in a 58-year-old, the diagnosis is often delayed further after symptoms first appear.

Does a late diagnosis mean the disease is more advanced?

It can, but not always. Because liver copper accumulation is the earliest event — occurring silently for years before symptoms — some people diagnosed late do have significant liver fibrosis or even established cirrhosis by the time they are diagnosed.⁵ Others, particularly those with hypomorphic variants, may have relatively mild liver involvement despite their age.

Neurological involvement at the time of late diagnosis varies. Some patients have had subtle neurological changes — mild tremor, slowed movements, slight changes in handwriting — for years before the diagnosis was made. Others present purely with liver findings and no neurological signs at all.³

Your specialist will assess both liver and neurological status carefully at diagnosis. This typically includes liver imaging and possibly a biopsy, copper studies (serum ceruloplasmin, 24-hour urine copper), and a slit-lamp eye examination for Kayser-Fleischer rings. If neurological symptoms are present, an MRI of the brain and neurological assessment will be part of the workup. For more on the diagnostic process, see how Wilson disease is diagnosed.

Do the treatments work the same way later in life?

The fundamental treatment approach is the same regardless of age: reduce the copper load that has built up, and then keep it controlled for the rest of your life.⁵⁶ The two main types of medication — chelating agents (which bind copper and pull it out through the urine) and zinc (which blocks intestinal copper absorption) — remain effective in older patients. There is no age at which these treatments stop working.

That said, your specialist will consider a few age-related factors when choosing and dosing your medication:

• Kidney function. Chelating agents are excreted by the kidneys. Age-related decline in kidney function may affect how well certain medications are tolerated, and your dosing will be calibrated to your renal function.⁶
• Other medications. Many people in their fifties and sixties take medicines for blood pressure, cholesterol, diabetes, or other conditions. Your Wilson disease specialist needs a full medication list to check for interactions.
• Bone density. D-penicillamine, one of the chelating agents, can affect connective tissue with long-term use. Your doctor will monitor for this. For more on all the medication options, see medications overview.
• Comorbidities. Pre-existing heart disease, diabetes, or other conditions do not prevent Wilson disease treatment, but they inform how your care team monitors your overall health.

Because the clinical experience with Wilson disease in older adults is thinner than in younger patients — most research cohorts skew younger — decisions about the best initial agent and target copper levels are somewhat more individualized at this age.⁵ This is a good reason to be seen at a center with experience in metabolic liver disease if one is accessible to you.

What about family screening?

A late-life diagnosis in you has direct implications for your children and siblings, because Wilson disease is an autosomal recessive condition. Your children have at least one abnormal ATP7B copy and, depending on your partner’s carrier status, may have two.³ Your siblings have a 25% chance of also having two defective copies.

Genetic testing of first-degree relatives is strongly recommended even after a late-life diagnosis in a parent or sibling — and especially so, because if the variant in your family is a milder one, affected relatives might also be silently accumulating copper without obvious symptoms.¹ Early detection in a relative, even before symptoms begin, is the best outcome: treatment started before symptoms appear is associated with excellent long-term results.⁶ See family screening for more detail on who should be tested and how.

Is the prognosis different when treatment starts later?

If liver cirrhosis is already present at diagnosis, the trajectory depends on how far along it is. Compensated cirrhosis — where the liver is scarred but still functioning — can stabilize and sometimes partially improve with treatment, because removing the copper stops the ongoing injury. Decompensated cirrhosis, where the liver is failing, may require transplant evaluation; Wilson disease is one of the conditions where liver transplant is curative from a metabolic standpoint.⁵⁶

For patients diagnosed late with purely liver disease and no significant cirrhosis, or with mild neurological involvement, the prognosis with prompt treatment is generally good. The goal of treatment at any age is the same: get copper under control, maintain that control indefinitely, and monitor for any residual or emerging complications.

The most important thing right now is to stay engaged with your care team. Medication adherence is the single biggest predictor of long-term outcome in Wilson disease — the diagnosis at 55 or 62 is not a death sentence, and many people treated successfully in later life go on to live normally for decades.⁶

This page is for patient education only and does not replace individualized medical advice. If you have recently received a Wilson disease diagnosis at any age, discuss your specific situation — including your mutation type, current organ involvement, and other medical conditions — with a specialist experienced in Wilson disease.

References